3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Advanced Solid Tumor
3
Neoplasm Metastasis
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumour
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
Cyclophosphamide
8
Mycophenolic Acid
6
Whole-Body Irradiation
5
Busulfan
5
fludarabine phosphate
4
fludarabine
4
Tacrolimus
4
Cyclosporine
4
Rituximab
3
Prednisone
3
Methotrexate
3
Inotuzumab Ozogamicin
3
Etoposide
3
Cytarabine
3
venetoclax
2
ruxolitinib
2
pegfilgrastim
2
blinatumomab
2
asciminib
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Mercaptopurine
2
Filgrastim
2
Dexamethasone
2
Calcium Dobesilate
2
tocilizumab
1
ricolinostat
1
rasburicase
1
ponatinib
1
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
tislelizumab
×
30 days
×
Clear all
No trials found.